Short Interest in ReShape Lifesciences Inc. (NASDAQ:RSLS) Grows By 25.6%

ReShape Lifesciences Inc. (NASDAQ:RSLS) was the target of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 29,900 shares, a growth of 25.6% from the November 30th total of 23,800 shares. Approximately 4.4% of the company’s stock are sold short. Based on an average daily trading volume, of 110,300 shares, the days-to-cover ratio is presently 0.3 days.

ReShape Lifesciences Trading Up 0.2 %

Shares of NASDAQ RSLS traded up $0.01 during mid-day trading on Tuesday, reaching $4.53. The company had a trading volume of 3,781 shares, compared to its average volume of 92,744. ReShape Lifesciences has a 52-week low of $4.09 and a 52-week high of $29.00. The firm has a 50 day simple moving average of $5.27 and a two-hundred day simple moving average of $8.05.

About ReShape Lifesciences

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.